[{"NetIncomeLoss_1_Q1_USD":-54402131.0,"GeneralAndAdministrativeExpense_1_Q1_USD":13881194.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":202414445.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":276000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q1_USD":0.0,"InterestIncomeOperating_1_Q1_USD":769237.0,"InterestPaidNet_1_Q1_USD":544315.0,"PaymentsToAcquireShortTermInvestments_1_Q1_USD":275408976.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-265708.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":22300000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-275115336.0,"Depreciation_1_Q1_USD":660697.0,"ProceedsFromSaleOfShortTermInvestments_1_Q1_USD":504464.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":162105030.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":762465.0,"ProceedsFromMinorityShareholders_1_Q1_USD":0.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":25974530.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":3001000.0,"AssetsCurrent_0_Q1_USD":588434836.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":17153244.0,"DueToRelatedPartiesCurrent_0_Q1_USD":768261.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":-1201789.0,"EquitySecuritiesFvNiUnrealizedLoss_1_Q1_USD":847958.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":4023000.0,"EquitySecuritiesFvNi_0_Q1_USD":3629891.0,"CommonStockSharesIssued_0_Q1_shares":209334036.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":434969528.0,"IncreaseDecreaseInAccountsReceivableRelatedParties_1_Q1_USD":-156808.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q1_USD":0.0,"Assets_0_Q1_USD":654863350.0,"OperatingLeaseLiability_0_Q1_USD":19835000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":4861.0,"ShortTermInvestments_0_Q1_USD":434969528.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":2983000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":39044418.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":27003000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":7463761.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":493000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-14419.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q1_USD":-847958.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":8978.0,"AccountsReceivableNetCurrent_0_Q1_USD":9911922.0,"CommonStockValue_0_Q1_USD":209333.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q1_USD":4377892.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":4735352.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":176927.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":160903241.0,"PaymentsOfStockIssuanceCosts_1_Q1_USD":531000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":518600000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-54411689.0,"AmortizationOfIntangibleAssets_1_Q1_USD":136770.0,"OtherAssetsNoncurrent_0_Q1_USD":25881934.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":83634176.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":17438841.0,"DebtSecuritiesAvailableForSaleRealizedLoss_1_Q1_USD":10000.0,"Liabilities_0_Q1_USD":73257201.0,"GainLossOnInvestments_1_Q1_USD":-10151.0,"EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_1_Q1_USD":0.0,"IncreaseDecreaseInOtherAccruedLiabilities_1_Q1_USD":35370.0,"EquityMethodInvestments_0_Q1_USD":0.0,"ShareBasedCompensation_1_Q1_USD":9595947.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":12463006.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":162105030.0,"IncreaseDecreaseInDerivativeLiabilities_1_Q1_USD":0.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":253000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":4000.0,"IncomeLossFromEquityMethodInvestments_1_Q1_USD":-434387.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":253000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":1597702.0,"Goodwill_0_Q1_USD":10513371.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":3834785.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":9595947.0,"IncreaseDecreaseInAccountsPayableRelatedParties_1_Q1_USD":125292.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-14419.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-52867428.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":4045000.0,"LiabilitiesCurrent_0_Q1_USD":41539450.0,"InterestExpense_1_Q1_USD":513034.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":83634176.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":59572236.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":2632996.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":3010000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.085,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":-75514.0,"AdditionalPaidInCapital_0_Q1_USD":1542261467.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":581606149.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":3010000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":32046.0,"DebtSecuritiesAvailableForSaleRealizedGain_1_Q1_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":10930312.0,"CommonStockSharesOutstanding_0_Q1_shares":209334036.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-8648045.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-167093942.0,"LeaseCost_1_Q1_USD":850000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"GoodwillGross_0_Q1_USD":10513371.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":8.34,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":7168000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":3063000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":19214780.0,"CommonStockSharesAuthorized_0_Q1_shares":600000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":371120.0,"OperatingIncomeLoss_1_Q1_USD":-52554492.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":-53967744.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":15378.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":10473761.0,"PreferredStockValue_0_Q1_USD":0.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-34963.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":654863350.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":384000.0,"OperatingExpenses_1_Q1_USD":52925612.0,"Capital_0_Q1_USD":546900000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.27,"ProfitLoss_1_Q1_USD":-54402131.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":64141.0,"StockholdersEquity_0_Q1_USD":581606149.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":75501.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":210824.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":434134291.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":6478.0,"AccountsReceivableRelatedPartiesCurrent_0_Q1_USD":346974.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-960598943.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":2395928.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":-54411689.0,"Ticker":"INO","CIK":"1055726","name":"INOVIO PHARMACEUTICALS, INC.","OfficialName":"Inovio Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"674206680.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210510"}]